Syros Pharmaceuticals, Inc. revenue for the last year amounted to 9.94 M USD, the most of which — 9.94 M USD — came from its highest performing source at the moment, Gene Control Medicines, the year earlier bringing 14.88 M USD. The greatest contribution to the revenue figure was made by United States — last year it brought Syros Pharmaceuticals, Inc. 9.94 M USD, and the year before that — 14.88 M USD.